Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-life outcomes of the PAUL® Glaucoma Implant with ripcord in refractory glaucoma.

Journal francais d'ophtalmologie·2026
Same author

[Phuc LeHoang: A giant in ophthalmology].

Journal francais d'ophtalmologie·2025
Same author

Autoantibody profiling to predict response to the anti-PD-1 therapy, pembrolizumab, in rare tumors.

ESMO open·2025
Same author

[Recommendations for rational use of new anti-VEGF biologicals].

Journal francais d'ophtalmologie·2025
Same author

[Infections in ophthalmology: State-of-the-art and perspectives].

Journal francais d'ophtalmologie·2024
Same author

[Viral retinitis].

Journal francais d'ophtalmologie·2024

Related Experiment Video

Updated: May 26, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

[Intravitreal injections: AFSSAPS guide to good practice].

B Bodaghi1, J F Korobelnik, I Cochereau

  • 1Service d'Ophtalmologie, Assistance-Publique Hôpitaux de Paris, CHU Pitié-Salpêtrière, Université Pierre et Marie Curie, 47-83 bd de l'Hôpital, 75013, Paris, France. bahram.bodaghi@psl.aphp.fr

Journal Francais D'Ophtalmologie
|January 10, 2012
PubMed
Summary

Updated guidelines simplify intravitreal injections for common eye conditions like macular degeneration. The focus remains on safety and preventing infections, incorporating expert experience for best practices.

More Related Videos

Intracameral Injection in Rats with Low Risk of Adverse Effects
06:19

Intracameral Injection in Rats with Low Risk of Adverse Effects

Published on: May 31, 2024

Intravitreal Injections in the Ovine Eye
03:37

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

Related Experiment Videos

Last Updated: May 26, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

Intracameral Injection in Rats with Low Risk of Adverse Effects
06:19

Intracameral Injection in Rats with Low Risk of Adverse Effects

Published on: May 31, 2024

Intravitreal Injections in the Ovine Eye
03:37

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

Area of Science:

  • Ophthalmology
  • Infectious Disease

Background:

  • Intravitreal injections are crucial for managing prevalent retinal diseases.
  • Previous guidelines for these procedures were updated in 2006.

Purpose of the Study:

  • To revise and update the guide to good practice for intravitreal injections.
  • To incorporate expert experience and simplify protocols while prioritizing safety.

Main Methods:

  • Expert consultation involving ophthalmologists, pharmacists, and hygienists.
  • Review and revision of existing best practice guidelines.

Main Results:

  • A simplified protocol for intravitreal injections is proposed.
  • Emphasis is placed on maintaining safety and preventing complications, particularly infections.

Conclusions:

  • Updated guidelines reflect accumulated experience in intravitreal injection procedures.
  • Simplification aims to improve practice efficiency without compromising patient safety.